Hollow Brook Wealth Management LLC Sells 23,957 Shares of Aflac Incorporated (NYSE:AFL)

Hollow Brook Wealth Management LLC reduced its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 28.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 61,031 shares of the financial services provider's stock after selling 23,957 shares during the period. Aflac comprises 2.0% of Hollow Brook Wealth Management LLC's portfolio, making the stock its 15th biggest position. Hollow Brook Wealth Management LLC's holdings in Aflac were worth $5,035,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Flputnam Investment Management Co. lifted its holdings in shares of Aflac by 0.5% in the 4th quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider's stock valued at $2,065,000 after buying an additional 122 shares during the period. Baystate Wealth Management LLC lifted its holdings in shares of Aflac by 24.1% in the 3rd quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider's stock valued at $52,000 after buying an additional 131 shares during the period. Brighton Jones LLC lifted its holdings in shares of Aflac by 2.3% in the 3rd quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider's stock valued at $472,000 after buying an additional 136 shares during the period. MV Capital Management Inc. lifted its holdings in shares of Aflac by 3.7% in the 3rd quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider's stock valued at $290,000 after buying an additional 136 shares during the period. Finally, Simon Quick Advisors LLC lifted its holdings in shares of Aflac by 4.9% in the 4th quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider's stock valued at $243,000 after buying an additional 139 shares during the period. 67.44% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Thomas J. Kenny sold 5,000 shares of the company's stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Thomas J. Kenny sold 5,000 shares of the company's stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the company's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares of the company's stock, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock worth $3,765,706 over the last ninety days. Corporate insiders own 0.80% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on AFL. Morgan Stanley boosted their price objective on Aflac from $80.00 to $84.00 and gave the company an "equal weight" rating in a report on Monday, April 15th. Keefe, Bruyette & Woods lifted their price target on Aflac from $83.00 to $87.00 and gave the company a "market perform" rating in a research note on Wednesday, April 10th. StockNews.com lowered Aflac from a "hold" rating to a "sell" rating in a research note on Wednesday, April 10th. Evercore ISI lowered Aflac from an "in-line" rating to an "underperform" rating and lifted their price target for the company from $76.00 to $78.00 in a research note on Thursday, January 4th. Finally, Piper Sandler lifted their price target on Aflac from $90.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, April 5th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $82.15.

Aflac Price Performance

NYSE:AFL traded down $0.90 during trading hours on Tuesday, hitting $83.64. 2,375,264 shares of the stock were exchanged, compared to its average volume of 2,271,133. Aflac Incorporated has a 52-week low of $64.10 and a 52-week high of $86.26. The firm's fifty day moving average price is $82.89 and its 200 day moving average price is $81.84. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The company has a market cap of $48.13 billion, a P/E ratio of 10.79, a P/E/G ratio of 2.29 and a beta of 0.91.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion for the quarter, compared to analysts' expectations of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter last year, the firm posted $1.29 earnings per share. As a group, equities research analysts anticipate that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.